← Open Payments lookup

CHRISTINA DEFAMIO: Open Payments

NPI 1134428527 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$359 in 12 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $249 · 2025 $359

Food & beverage: $359
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP3$116
Amgen Inc.1$73
TG Therapeutics, Inc.2$42
Biogen, Inc.2$41
ABBVIE INC.1$34
Otsuka America Pharmaceutical, Inc.1$19
Teva Pharmaceuticals USA, Inc.1$17
Genentech USA, Inc.1$16

Products named: UPLIZNA, BRIUMVI, LEQEMBI, UBRELVY, REXULTI, AUSTEDO XR, Ocrevus Zunovo.

Industry payments across PA — which companies pay providers there.